We are live on ! Find out more
GX

Greylock XII Portfolio holdings

AUM $51.9M
1-Year Est. Return 11.52%
This Fund
S&P 500
This Quarter Est. Return
+1.57%
1 Year Est. Return
-11.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$142M
AUM Growth
-$1.06M
Cap. Flow
+$4.17M
Cap. Flow %
2.93%
Top 10 Hldgs %
100%
Holding
4
New
2
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
KALA icon
KALA BIO
KALA
+$2.44M
2
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$1.73M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Real Estate 54.99%
2 Technology 42.5%
3 Healthcare 2.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDFN
1
DELISTED
Redfin
RDFN
$78.1M 54.99%
4,177,012
– –
CLDR
2
DELISTED
Cloudera, Inc.
CLDR
$60.4M 42.5%
3,419,865
– –
KALA icon
3
KALA BIO
KALA
$15.7M
$1.97M 1.39%
+80
New +$2.44M
RYTM icon
4
Rhythm Pharmaceuticals
RYTM
$7.75B
$1.6M 1.12%
+54,749
New +$1.73M

Similar funds

KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return
ZIM
ZPR Investment Management Orange City, Florida $46.8M AUM 2.45% 1-Year Est. Return
SCPM
Sagard Capital Partners Management New York $46.7M AUM 23.43% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return

Greylock XII's Q3 2018 Portfolio in Review

As of Q3 2018, Greylock XII held 4 positions worth $142M, down 0.74% from $143M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Greylock XII's Q3 2018 filing shows 2 new positions. Its largest new stake was KALA BIO: 80 shares worth $1.97M.

By sector, the portfolio is most concentrated in Real Estate at 55% of assets, down from 67% a quarter earlier, followed by Technology and Healthcare.

  • Greylock XII's largest Q3 2018 buy was KALA BIO: 80 shares worth $1.97M.
  • Greylock XII's ten largest holdings make up 100% of its $142M portfolio in Q3 2018.
  • Greylock XII opened 2 new positions and closed 0 in Q3 2018.
  • Greylock XII's portfolio value fell 0.74% quarter-over-quarter to $142M.

Based on Greylock XII's 13F filing for Q3 2018, filed 1 Nov 2018.